Pancreatic Cancer UK becomes an affiliate of Our Future Health
Pancreatic cancer is the 10th most common cancer with 10,449 people diagnosed in the UK in 2018. It has the lowest survival of all common cancers, with five-year survival less than 7%, with most people being diagnosed at a later stage of disease.
Pancreatic Cancer UK is dedicated to transforming the future for everyone with pancreatic cancer. Their vision is that everyone with pancreatic cancer survives to live long and well.
Our Future Health is joining with many of the UK’s leading health research charities who are providing valuable support and expertise to help develop Our Future Health. They will make a big impact in allowing us to ultimately change the way we prevent, detect and treat diseases.
Andrew Roddam, CEO of Our Future Health, said: “We are delighted to have the support of Pancreatic Cancer UK at this pivotal point in our programme. We look forward to working with them to ensure Our Future Health enhances and extends the opportunities to deliver life changing research designed to tackle this serious disease.”
Head of Research, Dr Chris MacDonald, said: “We are pleased to be joining Our Future Health as an affiliate charity. Information collected through this exciting initiative will provide valuable insight into the health of the nation over time, enabling us to learn more about a wide range of diseases, including pancreatic cancer, and study the signals present in blood samples even many years before diagnosis. This is particularly exciting for us as pancreatic cancer is frequently detected too late for treatment, with over 80% of people diagnosed in the late stages. The insights gained through Our Future Health will be invaluable and will doubtless help to improve early diagnosis and save lives.”
Read more about our partnerships.